SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-06-003735
Filing Date
2006-04-18
Accepted
2006-04-18 11:46:52
Documents
8
Period of Report
2006-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PHARMAFRONTIERS CORP. 8K a5125801.txt 8-K 17913
2 EXHIBIT 10.1 a5125801ex10_1.txt EX-10.1 94481
3 EXHIBIT 10.2 a5125801ex10_2.txt EX-10.2 42724
4 EXHIBIT 10.3 a5125801ex10_3.txt EX-10.3 36679
5 EXHIBIT 10.4 a5125801ex10_4.txt EX-10.4 3750
6 EXHIBIT 10.5 a5125801ex10_5.txt EX-10.5 26378
7 EXHIBIT 99.1 a5125801ex99_1.txt EX-99.1 5103
8 EXHIBIT 99.2 a5125801ex99_2.txt EX-99.2 5320
  Complete submission text file 0001157523-06-003735.txt   234390
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
PharmaFrontiers Corp. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25513 | Film No.: 06764023
SIC: 2834 Pharmaceutical Preparations